← All trials
NCT06103396
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 30, 2018
- Primary completion
- Jan 30, 2022
- Completion date
- Dec 30, 2024
- First posted
- Oct 26, 2023
- Last posted
- Oct 31, 2023
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Instituto Venezolano de Investigaciones CientificasLead sponsor
- Instituto Venezolano de Investigaciones CientificasReponsible party - principal investigator
- Instituto Venezolano de Investigaciones CientificasStudy chair
- Instituto Venezolano de Investigaciones CientificasSponsor investigator
- Instituto Venezolano de Investigaciones CientificasOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.